Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $119.3000 (1.1%) ($118.0200 - $120.4300) on Mon. May. 23, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.1% (three month average) | RSI | 48 | Latest Price | $119.3000(1.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND declines -0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.05% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.05% (StdDev 2.1%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
Resistance Level | $119.83 | 5 Day Moving Average | $118.68(0.52%) | 10 Day Moving Average | $118.29(0.85%) | 20 Day Moving Average | $119.83(-0.44%) | To recent high | -8.5% | To recent low | 29.8% | Market Cap | $1.917b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |